These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26951070)

  • 1. Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report.
    Ohtaka M; Kawahara T; Kumano Y; Maeda Y; Kondo T; Mochizuki T; Ishida H; Hattori Y; Teranishi J; Miyoshi Y; Yumura Y; Yao M; Inayama Y; Uemura H
    J Med Case Rep; 2016 Mar; 10():48. PubMed ID: 26951070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy.
    Kawahara T; Oshiro H; Sekiguchi Z; Ito H; Makiyama K; Uemura H; Kubota Y
    Int J Urol; 2011 Dec; 18(12):851-3. PubMed ID: 22004222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy.
    Chen J; Miranda G; Cai J; Daneshmand S; Djaladat H
    Scand J Urol; 2019; 53(2-3):123-128. PubMed ID: 31081431
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.
    Masson-Lecomte A; Xylinas E; Bouquot M; Sibony M; Allory Y; Comperat E; Zerbib M; de la Taille A; Rouprêt M
    World J Urol; 2015 Aug; 33(8):1087-93. PubMed ID: 25179011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
    Zaghloul MS; Christodouleas JP; Smith A; Abdallah A; William H; Khaled HM; Hwang WT; Baumann BC
    JAMA Surg; 2018 Jan; 153(1):e174591. PubMed ID: 29188298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of plasmacytoid variant of urothelial carcinoma of urinary bladder: systemic chemotherapy might be of benefit.
    Hayashi T; Tanigawa G; Fujita K; Imamura R; Nakazawa S; Yamamoto Y; Hosomi M; Shimazu K; Fushimi H; Yamaguchi S
    Int J Clin Oncol; 2011 Dec; 16(6):759-62. PubMed ID: 21732230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219).
    deVere White RW; Lara PN; Goldman B; Tangen CM; Smith DC; Wood DP; Hussain MH; Crawford ED
    J Urol; 2009 Jun; 181(6):2476-80; discussion 2480-1. PubMed ID: 19371909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
    Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM
    J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.
    North S; El-Gehani F; Santos C; Ghosh S; Lai R; Cass CE; Mackey JR
    J Urol; 2014 Jan; 191(1):35-9. PubMed ID: 23851183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid variant of urothelial carcinoma: a report of a rare case.
    Demellawy DE; Ahmed AD; Bora B; Bonin M
    Pathol Res Pract; 2012 Sep; 208(9):561-4. PubMed ID: 22854197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
    Zargar H; Shah JB; van Rhijn BW; Daneshmand S; Bivalacqua TJ; Spiess PE; Black PC; Kassouf W;
    J Urol; 2018 Jun; 199(6):1452-1458. PubMed ID: 29329894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmacytoid urothelial carcinoma of the bladder: a case report].
    Kawashima A; Ujike T; Nin M; Nishimura K; Miyoshi S
    Nihon Hinyokika Gakkai Zasshi; 2009 Jul; 100(5):590-4. PubMed ID: 19663248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.
    Gunaratne DA; Krieger LE; Maclean F; Vaux KJ; Chalasani V
    Clin Genitourin Cancer; 2016 Feb; 14(1):e103-5. PubMed ID: 26431887
    [No Abstract]   [Full Text] [Related]  

  • 14. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
    Sternberg CN; Skoneczna I; Kerst JM; Albers P; Fossa SD; Agerbaek M; Dumez H; de Santis M; Théodore C; Leahy MG; Chester JD; Verbaeys A; Daugaard G; Wood L; Witjes JA; de Wit R; Geoffrois L; Sengelov L; Thalmann G; Charpentier D; Rolland F; Mignot L; Sundar S; Symonds P; Graham J; Joly F; Marreaud S; Collette L; Sylvester R; ; ; ; ;
    Lancet Oncol; 2015 Jan; 16(1):76-86. PubMed ID: 25498218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Effective and Well Tolerated Strategy of Bladder Preservation Therapy in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
    Feng YH; Shen KH; Huang KH; Tzeng WS; Li CF; Lin KL
    Clin Genitourin Cancer; 2016 Feb; 14(1):e67-74. PubMed ID: 26428609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.
    Audenet F; Waingankar N; Ferket BS; Niglio SA; Marqueen KE; Sfakianos JP; Galsky MD
    J Urol; 2018 Nov; 200(5):996-1004. PubMed ID: 29879397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
    Amini E; Ahmadi N; Clifford TG; Hugen CM; Bazargani ST; Cai J; Miranda G; Sherrod AE; Daneshmand S; Djaladat H
    Int Urol Nephrol; 2019 Mar; 51(3):435-441. PubMed ID: 30706249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
    Dash A; Pettus JA; Herr HW; Bochner BH; Dalbagni G; Donat SM; Russo P; Boyle MG; Milowsky MI; Bajorin DF
    Cancer; 2008 Nov; 113(9):2471-7. PubMed ID: 18823036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
    Wang Z; Lu T; Du L; Hu Z; Zhuang Q; Li Y; Wang CY; Zhu H; Ye Z
    Int J Clin Exp Pathol; 2012; 5(6):601-8. PubMed ID: 22949945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.